Monitor

US Pension Risk Transfer Market Expected to See $10 Billion In Q3 Deal Volume

Retrieved on: 
Thursday, November 16, 2023

Legal & General Retirement America (LGRA), a leading provider of pension risk solutions in the United States, today released the Q3 2023 edition of the US Pension Risk Transfer Monitor, which analyzes industry trends and market outlooks in the US.

Key Points: 
  • Legal & General Retirement America (LGRA), a leading provider of pension risk solutions in the United States, today released the Q3 2023 edition of the US Pension Risk Transfer Monitor, which analyzes industry trends and market outlooks in the US.
  • Following the largest first half on record for the US Pension Risk Transfer (PRT) market at $22.5 billion in deal volume, the Monitor reports an expected $10 billion in Q3 PRT market volume.
  • While this is a decrease from last year’s third quarter, the market continues to exhibit rapid growth and total market volume is estimated to close at around $45 billion at the end of 2023 – the second largest year to date following 2022’s total of $51.9 billion.
  • “We’re seeing a truly well-rounded PRT market in terms of the types and sizes of deals transacting.

Rise of NDI Adoption Inspires Certification Program

Retrieved on: 
Thursday, December 7, 2023

STOCKHOLM, Dec. 7, 2023 /PRNewswire/ -- NDI, the tech company known for its widely adopted video connectivity standard, is shaping the next generation of products through its "NDI Certified program." Designed to increase harmonious interoperability, NDI's certification program plays an instrumental role within the dynamic and ever-growing NDI ecosystem of devices, applications, and workflows.

Key Points: 
  • Designed to increase harmonious interoperability, NDI's certification program plays an instrumental role within the dynamic and ever-growing NDI ecosystem of devices, applications, and workflows.
  • To support the rate of adoption of NDI users and innovation from manufacturers, the program ensures each new device and advancement made adheres to the NDI standard to enhance the connectivity experience for end users and installers alike.
  • Products that become NDI Certified have been thoroughly tested by the NDI team, validating that each NDI equipment can seamlessly communicate, exchange data, and function together.
  • We have been a proud member of the NDI Certification Program from the earliest days," said Steven Liang, VP of Product Development at Lumens.

Frazier Life Sciences Welcomes Lauren Mifflin as Vice President of Company Creation

Retrieved on: 
Thursday, November 30, 2023

MENLO PARK, Calif., Nov. 30, 2023 /PRNewswire/ -- Frazier Life Sciences (FLS), a longstanding venture capital firm investing in innovative biopharmaceuticals, is pleased to announce the appointment of Lauren Mifflin, Ph.D., as vice president of company creation.

Key Points: 
  • MENLO PARK, Calif., Nov. 30, 2023 /PRNewswire/ -- Frazier Life Sciences (FLS), a longstanding venture capital firm investing in innovative biopharmaceuticals, is pleased to announce the appointment of Lauren Mifflin, Ph.D., as vice president of company creation.
  • Lauren brings over 12 years of experience in building and growing life sciences and healthcare companies, making her a valuable addition to the FLS team.
  • "We are excited to welcome Lauren to Frazier Life Sciences," commented Dan Estes, Ph.D., general partner at FLS.
  • "Amidst challenging market cycles, I believe Frazier Life Sciences has solidified its position as a key player investing strategically across preclinical science and company creation," said Lauren Mifflin, Ph.D., vice president at FLS.

KalVista Pharmaceuticals to Present Data at the 2023 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology

Retrieved on: 
Thursday, November 2, 2023

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced the acceptance of multiple abstracts at the 2023 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI), taking place in Anaheim, CA from November 9-13.

Key Points: 
  • KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced the acceptance of multiple abstracts at the 2023 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI), taking place in Anaheim, CA from November 9-13.
  • The presentations are:
    Understanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment with Them - #P078: Bob Geng, Sally van Kooten, Markus Heckmann, Sherry Danese, Ledia Goga, Cristine Radojicic.
  • Results shared as an oral poster presentation and Q&A on Friday, November 10 from 4:30 - 4:45 pm PT at Monitor 13
    Treatment of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) –A Real-World ACARE Survey - #P059: Marcus Maurer, Markus Magerl, Marc A. Riedl, Sherry Danese, Julie Ulloa, Vibha Desai, Paul K. Audhya.
  • Results shared as an oral poster presentation and Q&A on Sunday, November 12 from 12:20 - 12:35 pm PT at Monitor 13
    All poster presentations will take place in the ePoster Section of the Exhibit Hall.

State of Delaware Selects Bamboo Health’s Behavioral Health Care Coordination Suite to Connect and Inform Providers Across the State

Retrieved on: 
Monday, October 23, 2023

The Division of Substance Abuse and Mental Health (DSAMH) of Delaware has selected Bamboo Health to implement its Behavioral Health Care Coordination Suite DTRN360 statewide.

Key Points: 
  • The Division of Substance Abuse and Mental Health (DSAMH) of Delaware has selected Bamboo Health to implement its Behavioral Health Care Coordination Suite DTRN360 statewide.
  • The agreement between the State of Delaware and Bamboo Health builds upon the state's current use of several key Bamboo Health applications within the Behavioral Care Coordination Suite, including the statewide Prescription Drug Monitoring Program (PDMP) and OpenBeds®.
  • Delaware has used OpenBeds (DTRN) for the past 5 years, which will integrate into the Behavioral Health Care Coordination suite with the new agreement.
  • To learn more about Bamboo Health’s Behavioral Health Care Coordination solution suite, please visit bamboohealth.com/solutions/behavioral-health-care-coordination .

TriState Capital Bank Named a Leading Equipment Finance Company by Monitor for 4th Consecutive Year

Retrieved on: 
Friday, October 20, 2023

For the fourth consecutive year, TriState Capital Bank was recognized by Monitor as one of the top-performing equipment finance companies in the United States.

Key Points: 
  • For the fourth consecutive year, TriState Capital Bank was recognized by Monitor as one of the top-performing equipment finance companies in the United States.
  • The bank’s 44.9% year-over-year gain in total assets in 2022 landed TriState Capital at No.
  • In its fifth year, TriState Capital’s Equipment Finance division grew its assets to $346.5 million in 2022 from $239.1 million in 2021.
  • The list is an annual report of the largest equipment finance and leasing companies in the United States.

Night Vision Device Market worth $11.2 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, October 19, 2023

Portable night vision devices are experiencing increasing demand due to a range of driving factors.

Key Points: 
  • Portable night vision devices are experiencing increasing demand due to a range of driving factors.
  • The increasing population and need for security and surveillance in these countries are projected to drive the night vision devices market during the forecast period.
  • The night vision devices market in Asia Pacific is expected to record the highest CAGR during the forecast period.
  • China, Japan, and India are among the major countries driving the night vision devices market in the region.

Night Vision Device Market worth $11.2 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, October 19, 2023

Portable night vision devices are experiencing increasing demand due to a range of driving factors.

Key Points: 
  • Portable night vision devices are experiencing increasing demand due to a range of driving factors.
  • The increasing population and need for security and surveillance in these countries are projected to drive the night vision devices market during the forecast period.
  • The night vision devices market in Asia Pacific is expected to record the highest CAGR during the forecast period.
  • China, Japan, and India are among the major countries driving the night vision devices market in the region.

BankFinancial names Kimberly King, Vice President of Sales of their Equipment Finance Small Ticket Division

Retrieved on: 
Tuesday, September 19, 2023

BURR RIDGE, Ill., Sept. 19, 2023 (GLOBE NEWSWIRE) -- BankFinancial announced the promotion of Kimberly King, CLFP as Vice President of Sales of the Equipment Finance Small Ticket Division.

Key Points: 
  • BURR RIDGE, Ill., Sept. 19, 2023 (GLOBE NEWSWIRE) -- BankFinancial announced the promotion of Kimberly King, CLFP as Vice President of Sales of the Equipment Finance Small Ticket Division.
  • Before being promoted to Vice President, she served as the Small Ticket Sales Manager.
  • In this role, she was responsible for the Small Ticket leasing sales operation, including developing and executing division initiatives in sales, marketing, product, and operations.
  • Marci L. Slagle, CLFP, President of BankFinancial Equipment Finance, believes Kim is the ideal addition to lead the Equipment Finance Small Ticket division to its next chapter of growth and success.

Medical Board Reform Bill That Will Expand Patients' Voice in Doctor Disciplinary Process Heads to Governor Newsom, Says Consumer Watchdog

Retrieved on: 
Friday, September 15, 2023

However key reforms were stripped from the medical board bill that would have further strengthened patient safety and doctor oversight in California.

Key Points: 
  • However key reforms were stripped from the medical board bill that would have further strengthened patient safety and doctor oversight in California.
  • Injured patients and the families of those lost to medical negligence have spent years calling for these changes.
  • The bill as sent to the governor will increase fees to $1151 in 2023 and $1250 in 2027.
  • Two years ago, the legislature delayed substantive reform of the enforcement process and board operations by appointing an Enforcement Monitor to make recommendations.